A Novel Ureteric Stent in Kidney Stone Patients and Oncology Patients Compared to a Conventional JJ Stent

Summary

Urological stents and catheters often lead to inflammation, causing pain and infection in the urinary tract. Moreover, 80% of stents are associated with pain, negatively impacting on QoL and mental health. Offering novel designs with significantly lower E\&B leads to a reduction in UTIs and improves QoL. Reducing hospital admissions (from 3 to 1 per patient, annually) would free \>100,000 bed-nights, allowing the elderly to regain independence. Our proposed research could have a significant impact towards fulfilling the 'healthy-ageing' Grand Challenge. Additionally, the novel stent reduces prevalence of infections and therefore, of antibiotic prescriptions contributing to the Global AMR challenge.

Eligibility

Inclusion Criteria:

1. Aged 18 years or over
2. Ureteric stents clinically indicated either due to kidney stones or abdominal/pelvic cancers compressing ureters
3. Previous experience with ureteric stents
4. Awaiting insersion/replacement of stents
5. Ability to give consent
6. Ability to interact with study documentation
7. Sufficient English to complete study documentations and questionnaires

Exclusion Criteria:

1. Expected survival \<4months
2. Unfit for stent insertion
3. Unable to comply with study processes Pregnancy

Conditions4

Browse More Trials